Levomilnacipran Completed Phase 0 Trials for Tobacco Use Disorders Other

IndicationsStatusPurposePhase
CompletedOther0
clinicaltrials.gov IdentifierTitleDrugs
NCT02265367Novel Medication as a Potential Smoking Cessation Aid